The global Metabolomics Market was valued at USD 1.15 billion in 2016 and is projected to reach USD 3.91billion by 2025, growing at a CAGR of 14.54% from 2017 to 2025.
Metabolomics is the scientific study of chemical processes involving metabolites. Specifically, metabolomics is the systematic study of the unique chemical fingerprints that specific cellular processes leave behind,
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Availability of Government and Private Funding
1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
1.3 Technological Advancements
1.4 Growing Demand for Personalized Medicine
1.5 Increasing Use of Metabolomics in Toxicology Testing
2. Market Restraints
2.1 Issues Related to Data Examination and Processing
2.2 High Cost of equipment
Market Segmentation:
1. Global MetabolomicsMarket, by Indication:
1.1 Cancer
1.2 Cardiovascular Disorders
1.3 Neurological Disorders
1.4 Inborn Errors of Metabolism
1.5 Other Indications
2. Global MetabolomicsMarket, by Application:
2.1 Biomarker Discovery
2.2 Drug Discovery
2.3 Toxicology Testing
2.4 Nutrigenomics
2.5 Functional Genomics
2.6 Personalized Medicine
2.7 Other Applications
3. Global MetabolomicsMarket, by Product and Services:
3.1 Metabolomics Instruments
3.1.1 Separation Tools
3.1.1.1 High-Performance Liquid Chromatography
3.1.1.2 Gas Chromatography
3.1.1.3 Ultra-Performance Liquid Chromatography
3.1.1.4 Capillary Electrophoresis
3.1.2 Detection Tools
3.1.2.1 Mass Spectrometry
3.1.2.2 Nuclear Magnetic Resonance Spectroscopy
3.1.2.3 Surface-Based Mass Analysis
3.2 Metabolomics Bioinformatics tools and services
3.2.1 Bioinformatics Tools & Databases
3.2.2 Bioinformatics Services
4. Global Metabolomics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Agilent Technologies, Inc.
3. Waters Corporation
4. Danaher Corporation
5. Shimadzu Corporation
6. Biocrates Life Sciences AG
7. Bio-Rad Laboratories, Inc.
8. Bruker Corporation
9. Human Metabolome Technologies, Inc.
10. Leco Corporation
11. Metabolon, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the MetabolomicsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL METABOLOMICSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL METABOLOMICSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL METABOLOMICS MARKET, BY INDICATION
5.1 Cancer
5.2 Cardiovascular Disorders
5.3 Neurological Disorders
5.4 Inborn Errors of Metabolism
5.5 Other Indications
6 GLOBAL METABOLOMICS MARKET, BY APPLICATION
6.1 Biomarker Discovery
6.2 Drug Discovery
6.3 Toxicology Testing
6.4 Nutrigenomics
6.5 Functional Genomics
6.6 Personalized Medicine
6.7 Other Applications
7 GLOBAL METABOLOMICS MARKET, BY PRODUCT AND SERVICES
7.1 Metabolomics Instruments
7.1.1 Separation Tools
7.1.1.1 High-Performance Liquid Chromatography
7.1.1.2 Gas Chromatography
7.1.1.3 Ultra-Performance Liquid Chromatography
7.1.1.4 Capillary Electrophoresis
7.1.2 Detection Tools
7.1.2.1 Mass Spectrometry
7.1.2.2 Nuclear Magnetic Resonance Spectroscopy
7.1.2.3 Surface-Based Mass Analysis
7.1.3 Metabolomics Bioinformatics tools and services
7.1.4 Bioinformatics Tools & Databases
7.1.5 Bioinformatics Services
8 GLOBAL METABOLOMICSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL METABOLOMICSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Thermo Fisher Scientific Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Agilent Technologies, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Waters Corporation
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Danaher Corporation
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Shimadzu Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Biocrates Life Sciences AG
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Bio-Rad Laboratories, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Bruker Corporation
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Human Metabolome Technologies, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Leco Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Metabolon, Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
11 Appendix
11.1 Related Reports
Overview of the Global Metabolomics Core Facilities Market:
The report discusses everything a marketer requires before investing in the global Metabolomics Core Facilities Market during the forecast period 2023-2030...
Description
Metabolomics is a rapidly evolving field of scientific research that focuses on the comprehensive study of metabolites, the small molecules produced during metabolic processes in living organisms. It involves the identification, quantification, and analysis of these metabolites to ...
Overview of the Global Metabolomics Biomarker Services Market:
The report discusses everything a marketer requires before investing in the global Metabolomics Biomarker Services Market during the forecast period 202...
Overview of the Global Metabolomics Services Market:
The report discusses everything a marketer requires before investing in the global Metabolomics Services Market during the forecast period 2023-2030. It provides ...
Overview of the Global Spatially Resolved Metabolomics Market:
The report discusses everything a marketer requires before investing in the global Spatially Resolved Metabolomics Market during the forecast period 202...
Overview of the Global Microbial Metabolomics Market:
The report discusses everything a marketer requires before investing in the global Microbial Metabolomics Market during the forecast period 2023-2030. It provide...
The global Metabolomics Biomarker market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Metabolomics Report by Material, Application, and Geography - Global Forecast to 2027 is a professional and comprehensive research report on the world's major regional market conditions, focusing...
The global Metabolomics market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field e...
The Bioinformatics Market is predicted to reach US$ ~83.94 billion by 2031 from US$ ~22.24 billion in 2020, and to grow at a CAGR of ~14.2% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (count...